These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9094124)

  • 1. IL-4 may unlock asthma and allergic diseases.
    Kling J
    Nat Biotechnol; 1997 Apr; 15(4):316-7. PubMed ID: 9094124
    [No Abstract]   [Full Text] [Related]  

  • 2. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.
    Wegmann M
    Expert Rev Mol Diagn; 2009 Jan; 9(1):85-100. PubMed ID: 19099351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma.
    Chung F
    Mediators Inflamm; 2001 Apr; 10(2):51-9. PubMed ID: 11405550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13 in asthma pathogenesis.
    Wills-Karp M
    Immunol Rev; 2004 Dec; 202():175-90. PubMed ID: 15546393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-based immunotherapy of allergic disease.
    Lewkowich IP; HayGlass KT
    Arch Immunol Ther Exp (Warsz); 2001; 49(4):293-302. PubMed ID: 11726032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of interleukin-4, and -13 in the pathogenesis of allergic diseases].
    Izuhara K
    Rinsho Byori; 2001 Apr; 49(4):360-4. PubMed ID: 11391949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor beta2 chain expression in patients with allergic asthma.
    Tazaki T; Minoguchi K; Yokoe T; Oda N; Hashimoto T; Tanaka A; Okada S; Yamamoto Y; Watanabe Y; Adachi M
    Cell Immunol; 2004 Mar; 228(1):20-6. PubMed ID: 15203316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding how interleukin 13 signals are involved in the pathogenesis of bronchial asthma.
    Izuhara K; Umeshita-Suyama R; Akaiwa M; Shirakawa T; Deichmann KA; Arima K; Hamasaki N; Hopkin JM
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):505-12. PubMed ID: 11197605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils.
    Cohn L; Homer RJ; MacLeod H; Mohrs M; Brombacher F; Bottomly K
    J Immunol; 1999 May; 162(10):6178-83. PubMed ID: 10229862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of interleukin-4 activity by soluble interleukin-4 receptors.
    Enssle K; Schulz G
    J Clin Lab Anal; 1995; 9(6):450-5. PubMed ID: 8587015
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
    Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
    Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine regulation of mucus production in a model of allergic asthma.
    Cohn L; Whittaker L; Niu N; Homer RJ
    Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the IL-4 receptor: why, how, and for whom?
    Duschl A
    Eur Cytokine Netw; 2000 Sep; 11(3):521-2. PubMed ID: 11203204
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma.
    Wang CC; Fu CL; Yang YH; Lo YC; Wang LC; Chuang YH; Chang DM; Chiang BL
    Gene Ther; 2006 Oct; 13(19):1414-21. PubMed ID: 16724092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
    Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
    Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific immunotherapy in allergic asthma].
    Bergmann KC
    Pneumologie; 2003 Feb; 57(2):84-90. PubMed ID: 12579463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
    Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
    Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interleukin-13 in infectious diseases and allergy.
    Brombacher F
    Bioessays; 2000 Jul; 22(7):646-56. PubMed ID: 10878577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma.
    Nishikubo K; Murata Y; Tamaki S; Sugama K; Imanaka-Yoshida K; Yuda N; Kai M; Takamura S; Sebald W; Adachi Y; Yasutomi Y
    Gene Ther; 2003 Dec; 10(26):2119-25. PubMed ID: 14625566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.